CLOPIDOGREL VS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS

氯吡格雷与阿司匹林治疗有缺血事件风险的患者

• 批准号: 3764495
• 负责人: WAYNE M CLARK
• 金额: --
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3764495
• 关键词: aspirin; cardiovascular disorder chemotherapy; cerebral ischemia /hypoxia; clinical trials; disease /disorder prevention /control; disease /disorder proneness /risk; drug administration rate /duration; drug screening /evaluation; human subject; human therapy evaluation; longitudinal human study; platelet aggregation inhibitors; stroke

This is a triple-blind, randomized study with two parallel groups: Clopidogrel 75 mg daily vs aspirin 325 mg. The study will take people who have had strokes within six months of randomization and will follow them for three years to assess the relative efficacy of Clopidogrel vs aspirin in reducing the incidence of the composite outcome of ischemic stroke, as well as the relative safety and tolerability of the two drugs.

这是一项三盲随机研究，有两个平行组： 氯吡格雷每天 75 毫克 vs 阿司匹林 325 毫克。 这项研究将带人们 谁在随机分组后六个月内发生过中风并且将遵循 他们花了三年的时间来评估氯吡格雷与氯吡格雷的相对疗效 阿司匹林降低缺血性综合结局的发生率 中风，以及两种药物的相对安全性和耐受性。